- Report
- November 2025
- 185 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- October 2025
- 197 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Clinical Trials
- April 2025
- 240 Pages
Global
From €2117EUR$2,400USD£1,854GBP
€2647EUR$3,000USD£2,318GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €1765EUR$2,000USD£1,545GBP
€2206EUR$2,500USD£1,931GBP
- Report
- May 2025
- 196 Pages
Global
From €4191EUR$4,750USD£3,670GBP
- Report
- October 2025
- 250 Pages
Global
From €3961EUR$4,490USD£3,469GBP
- Report
- October 2025
- 250 Pages
Global
From €3961EUR$4,490USD£3,469GBP
- Report
- September 2025
- 250 Pages
Global
From €3961EUR$4,490USD£3,469GBP
- Report
- December 2025
- 177 Pages
Global
From €5161EUR$5,850USD£4,519GBP
- Report
- December 2025
- 194 Pages
Global
From €5161EUR$5,850USD£4,519GBP
- Report
- November 2025
- 185 Pages
Global
From €3970EUR$4,500USD£3,476GBP
- Report
- April 2025
- 186 Pages
Global
From €3970EUR$4,500USD£3,476GBP
- Report
- August 2025
- 136 Pages
Global
From €2249EUR$2,549USD£1,969GBP
€2646EUR$2,999USD£2,317GBP
- Report
- January 2025
- 105 Pages
Global
From €3500EUR$4,250USD£3,172GBP
- Report
- October 2025
- 160 Pages
Global
From €2962EUR$3,358USD£2,594GBP
€3485EUR$3,950USD£3,052GBP
- Report
- October 2025
- 100 Pages
United States
From €5249EUR$5,950USD£4,597GBP
- Report
- July 2025
- 82 Pages
United States
From €3088EUR$3,500USD£2,704GBP
- Report
- May 2025
- 120 Pages
Global
From €5249EUR$5,950USD£4,597GBP
- Report
- August 2025
- 183 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- August 2025
- 184 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more